Products

TAP Products

Lead Product: TAP 20™ for Point-of-Care Testing

Point-of-Care Testing has grown into $5 billion worldwide market because of the many advantages it offers over centralized testing. Obtaining lab results while a patient is still in their physician's office enables more informed and efficient care decisions. In many ambulatory care settings, blood sampling can be a significant barrier to adoption of point of care testing, as it requires trained personnel, creates anxiety and discomfort for patients, and can disrupt workflow

TAP 20™, Seventh Sense's lead product in development, collects up to 20 microliters of whole blood – sufficient volume for many routine point-of-care blood tests, and has several advantages over current fingerstick lancing methods:

• Painless for the patient
• Sample is contained until used for testing
• Simple, one-step process
• No sharps disposal
• Standardized, consistent collection technique

In addition to TAP 20™, Seventh Sense is developing several products integrating the novel TAP blood collection technology, including:

• TAP 100™ for point-of-care panels and tests requiring up to 100 microliters of blood; the development of TAP 100 is supported by a grant from the Gates Foundation
• On Vivo™ diagnostics, integrating TAP collection with assay chemistry and electronics for one-step testing from collection to result